One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Eastern Europe,Australasia,Asia
Sample Provided: no
Payment Terms: L/L
Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Larotrectinib intermediates 5-Chloro-3-nitropyrazolo[1,5-a]pyrimidine (CAS No.: 1363380-51-1) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.
Larotrectinib (tradename Vitrakvi) is a drug for the treatment of cancer. It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC.